Physician profile
Daniel Owen Ryan
NPI 1376569327
$6,313.24
in general payments reported to CMS, 2019-2025
9 companies · $58.58 in 2025
The $58.58 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,020 · 2020: $720 · 2021: $168 · 2022: $630 · 2023: $521 · 2024: $196 · 2025: $58.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovasis INC | $3,139.89 | 2019 | |
| Medtronic, INC. | $1,119.40 | 2021-2023 | Mazor X System, Catalyft Pl Expandable Interbody System, Cd Horizon Spinal System |
| Orthofix Medical, INC. | $1,060.47 | 2019-2024 | Spinal-Stim, Physio-Stim |
| Medtronic USA, INC. | $722.04 | 2019-2020 | |
| Alevio, LLC | $123.53 | 2019 | |
| Bioventus LLC | $61.72 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Ethicon US, LLC | $39.46 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $32.45 | 2025 | Zilretta, Iovera, Exparel |
| Sanofi-Aventis U.S. LLC | $14.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.